Columnist Matt Levine takes a look at the ongoing lawsuit between Pershing Square and Allergan, recent stock buybacks and Ponzi schemes.
Columnist Matt Levine takes a look at the ongoing lawsuit between Pershing Square and Allergan, recent stock buybacks and Ponzi schemes.